State Street’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

State Street’s Portfolio CMRA Stock Details CMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-29,600	Closed	-$9.44K	–	4547
2023 Q3	$9.44K	Hold	29,600	–	–	﹤0.01%	4512
2023 Q2	$14.4K	Hold	29,600	–	–	﹤0.01%	4625
2023 Q1	$26.6K	Hold	29,600	–	–	﹤0.01%	4641
2022 Q4	$36.4K	Buy	+29,600	New	+$43.3K	﹤0.01%	4627

State Street's CMRA Position: Q4 2023 in Review

State Street sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2023, closing a stake of 29,600 shares — an estimated $9.44K sold.

State Street first reported a position in CMRA in Q4 2022 and held it in 4 quarters. The position peaked at $36.4K in Q4 2022. 0 funds tracked by Wall St. Rank hold CMRA as of Q4 2023.

State Street reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
State Street sold 29,600 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2023, an estimated $9.44K.
State Street first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q4 2022 and held it in 4 quarters.
State Street's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $36.4K in Q4 2022.
0 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2023.

Based on State Street's 13F filing for Q4 2023, filed 14 Feb 2024.